CONSOLIDATED STATEMENT OF CASH FLOWS - USD ($) $ in Thousands		12 Months Ended
		Apr. 27, 2024	Apr. 29, 2023	Apr. 30, 2022
Cash flows from operating activities
Net income		$ 124,636	$ 151,941	$ 152,328
Adjustments to reconcile net income to cash provided by operating activities
(Gain)/loss on disposal and impairment of assets		1,101	6,365	(13,657)
(Gain)/loss on sale of investments		(1,199)	148	(478)
Provision for doubtful accounts		511	1,546	(617)
Depreciation and amortization		48,552	40,193	39,771
Amortization of right-of-use lease assets		76,133	76,511	72,942
Lease impairment/(settlement)		(1,175)	1,347	0
Equity-based compensation expense		14,426	12,458	11,858
Change in deferred taxes		(3,268)	3,895	1,022
Change in receivables		(16,811)	53,675	(41,829)
Change in inventories		19,877	32,311	(72,022)
Change in other assets		10,303	24,377	(16,232)
Change in payables		(8,606)	4,586	6,326
Change in lease liabilities		(76,766)	(77,811)	(73,805)
Change in other liabilities		(29,587)	(126,375)	13,397
Net cash provided by operating activities		158,127	205,167	79,004
Cash flows from investing activities
Proceeds from disposals of assets		4,972	136	22,588
Capital expenditures		(53,551)	(68,812)	(76,580)
Purchases of investments		(18,351)	(9,092)	(34,152)
Proceeds from sales of investments		24,816	24,483	36,096
Acquisitions		(39,440)	(16,835)	(26,323)
Net cash used for investing activities		(81,554)	(70,120)	(78,371)
Cash flows from financing activities
Payments on debt and finance lease liabilities		(489)	(123)	(121)
Holdback payments for acquisitions		(5,000)	(5,000)	(23,000)
Stock issued for stock and employee benefit plans, net of shares withheld for taxes		10,872	2,857	(1,818)
Repurchases of common stock		(52,773)	(5,004)	(90,645)
Dividends paid to shareholders		(32,665)	(29,869)	(27,717)
Dividends paid to minority interest joint venture partners	[1]	(1,172)	0	(1,260)
Net cash used for financing activities		(81,227)	(37,139)	(144,561)
Effect of exchange rate changes on cash and equivalents		(926)	(86)	(1,919)
Change in cash, cash equivalents and restricted cash		(5,580)	97,822	(145,847)
Cash, cash equivalents and restricted cash at beginning of period		346,678	248,856	394,703
Cash, cash equivalents and restricted cash at end of period		341,098	346,678	248,856
Supplemental disclosure of non-cash investing activities
Capital expenditures included in accounts payable		$ 5,952	$ 8,208	$ 9,234

[1] Includes dividends paid to joint venture minority partners resulting from the repatriation of dividends from our foreign earnings that we no longer consider permanently reinvested.